Question

I am a breastfeeding mother and i want to know if it is safe to use Chylothorax? Is Chylothorax safe for nursing mother and child? Does Chylothorax extracts into breast milk? Does Chylothorax has any long term or short term side effects on infants? Can Chylothorax influence milk supply or can Chylothorax decrease milk supply in lactating mothers?

Chylothorax lactation summary

Chylothorax usage has low risk in breastfeeding
  • DrLact safety Score for Chylothorax is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of Chylothorax may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that Chylothorax may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of Chylothorax low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using Chylothorax We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Chylothorax usage in lactation

Chylothorax is the result of pleural effusion caused by accumulation of chyle or lymphatic fluid in the pleural cavity. In the first months of life it occurs after correction surgery of congenital heart anomalies like heart defects, esophageal atresia or diaphragmatic hernia. Some are congenital in origin associated or not with other defects (mostly chromosomic derangements). Conservative treatments are intended to minimize or avoid lymphatic flux in order to attain the defect closure. Seventy percent of patients ameliorate by the use of especial long-chain free and middle-chain triglyceride (MCT) enriched formulas. Fat-free human milk obtained by centrifugation, enriched or not with middle chain triglycerides, has been successfully used as a treatment. Fully fasting and total parenteral nutrition is sometimes needed. Octreotide (octapeptide somatostatin analogue) may be another option. The mean for normal feeding initiation is 9 days (3 to 59 days), thus it is important to know if milk production is desirable to maintain by means of frequent pump extraction and freezing. The best result among different conservative treatments is not clearly defined. Corrective surgery is a difficult decision when conservative treatments have failed.
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.